Sunshine Biopharma, Inc. Announces Closing of $8.0 Million Private Placement Priced At-the-Market

MONTREAL, March 14, 2022 (GLOBE NEWSWIRE) — Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a pharmaceutical…

Related Keywords

United States ,Montreal ,Quebec ,Canada ,Toronto ,Ontario ,Camille Sebaaly ,Mcgill University Jewish ,Company Or Sunshine Biopharma ,Nasdaq ,University Of Georgia ,Exchange Commission ,Sunshine Biopharma Inc ,Postmedia Network Inc ,Securities Exchange ,College Of Pharmacy ,University Of Arizona ,Aegis Capital Corp ,University Of Arizona Plpro ,Sunshine Biopharma ,Announces Closing ,Private Placement Priced At The Market ,Common Stock ,Pre Funded Warrant ,Investor Warrants ,Investor Warrant ,Pre Funded Warrants ,Exclusive Placement Agent ,Securities Act ,Acute Respiratory ,Multidrug Resistant Cancer Cells ,Pancreatic Cancer ,Small Cell Lung Cancer ,Breast Cancer ,Uterine Sarcoma ,Mcgill University ,Jewish General Hospital ,Securities Exchange Act ,Additional Information ,Biopharma Media Contacts ,Postmedia Network ,Street East ,